MindMaze Therapeutics Holding (CHIX:MMTXZ) Common Stock: CHF15.41 Mil (As of Dec. 2025)


CHIX:MMTXZ MindMaze Therapeutics Holding SA CHIX:MMTXZ
15 GF Score
Price CHF0.21
! 2 Warning Signs
View Full Analysis

What is MindMaze Therapeutics Holding Common Stock?

MindMaze Therapeutics Holding CHIX:MMTXZ +4.74% 15 Common Stock is CHF15.41 Mil as of Dec. 2025. GuruFocus rates CHIX:MMTXZ with a GF Score™ of 15/100. The stock has 2 warning signs investors should review.

MindMaze Therapeutics Holding's quarterly common stock increased from . 20 (CHF0.00 Mil) to Dec. 2024 (CHF1.40 Mil) and increased from Dec. 2024 (CHF1.40 Mil) to Dec. 2025 (CHF15.41 Mil).

MindMaze Therapeutics Holding's annual common stock increased from . 20 (CHF0.00 Mil) to Dec. 2024 (CHF1.40 Mil) and increased from Dec. 2024 (CHF1.40 Mil) to Dec. 2025 (CHF15.41 Mil).

MindMaze Therapeutics Holding Common Stock Historical Data

* Premium members only.

The historical data trend for MindMaze Therapeutics Holding's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MindMaze Therapeutics Holding Common Stock Chart

MindMaze Therapeutics Holding Annual Data
Trend Dec24 Dec25
Common Stock
1.40 15.41

MindMaze Therapeutics Holding Semi-Annual Data
Dec24 Dec25
Common Stock 1.40 15.41
CHIX:MMTXZ
15GF Score
MindMaze Therapeutics Holding SA CHIX:MMTXZ
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MindMaze Therapeutics Holding Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of CHF15.41 Mil mean?
MindMaze Therapeutics Holding (CHIX:MMTXZ) has a Common Stock of CHF15.41 Mil as of Dec. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on MindMaze Therapeutics Holding and its competitors.
Is MindMaze Therapeutics Holding's Common Stock too high?
MindMaze Therapeutics Holding's current Common Stock is CHF15.41 Mil. Overall, MindMaze Therapeutics Holding has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does MindMaze Therapeutics Holding's Common Stock compare to VRTX and REGN?
MindMaze Therapeutics Holding's Common Stock of CHF15.41 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on MindMaze Therapeutics Holding and its competitors. MindMaze Therapeutics Holding's current Common Stock is CHF15.41 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MindMaze Therapeutics Holding stock overvalued right now?
MindMaze Therapeutics Holding (CHIX:MMTXZ) has a current Common Stock of CHF15.41 Mil. The current Common Stock is CHF15.41 Mil. MindMaze Therapeutics Holding's overall GF Score™ is 15/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For MindMaze Therapeutics Holding (CHIX:MMTXZ), the current Common Stock is CHF15.41 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MindMaze Therapeutics Holding Business Description

Other Exchanges RLFTY:USAMMTX:Switzerland
Address Avenue de Secheron 15, Geneva, CHE, 1202
MindMaze Therapeutics Holding SA is a Swiss-based, commercial-stage biopharmaceutical and neurotechnology company. The company develops and commercializes digital treatments for neurological diseases and brain disorders. Its technology platform integrates software, sensors, and telehealth, and its solutions are used in clinical and home settings internationally. The company has developed evidence-based, next-generation neurotherapeutics that provide evidence-based motor and cognitive treatments to redefine clinical outcomes in patients with neurological disease and brain disorders. The company also manages Relief's existing portfolio of clinical and commercial biopharmaceutical assets focused on rare dermatological, metabolic, and respiratory diseases.
15GF Score

Get the complete analysis for CHIX:MMTXZ

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF0.21
Price